Frequency of Abnormal Findings Detected by Comprehensive Clinical Evaluation at 1 Year after Allogeneic Hematopoietic Cell Transplantation
Open Access
- 13 February 2009
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 15 (4) , 416-420
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantationBlood, 2007
- A Prospective Cohort Study of Late Sequelae of Pediatric Allogeneic Hematopoietic Stem Cell TransplantationMedicine, 2007
- Bisphosphonate Therapy for Reduced Bone Mineral Density in Children with Chronic Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2007
- Increased Risk of Bone Loss without Fracture Risk in Long-Term Survivors after Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2007
- Chronic GVHD and Pretransplantation Abnormalities in Pulmonary Function Are the Main Determinants Predicting Worsening Pulmonary Function in Long-term Survivors after Stem Cell TransplantationTransplantation and Cellular Therapy, 2006
- Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor studyBlood, 2006
- Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor StudyBlood, 2006
- Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor StudyBlood, 2004
- Nonmalignant late effects after allogeneic stem cell transplantationBlood, 2003
- Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective studyTransplantation and Cellular Therapy, 2001